Morita K, et al. - Using propensity score analyses, researchers determined whether treatment with early systemic corticosteroids impacts the in-hospital mortality of patients hospitalized with Stevens–Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN). They identified inpatients aged ≥ 18 years who were admitted with SJS or TEN using the Japanese Diagnosis Procedure Combination Database, a large nationwide inpatient administrative claims database. According to findings, early systemic corticosteroid therapy was not associated with lower in-hospital mortality in patients with SJS or TEN.